HomeAdvocacy Advocacy News

Advocacy News

Displaying results 1-10 (of 123)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >| 

State Advocacy Spotlight: Step Therapy Legislation Continues to Progress in Florida

Like other states across the country, efforts to address step therapy in Florida are underway and making great progress as key legislation continues to move forward.

READ MORE

Biosimilars Bill Signed in Kansas

On April 13, HB 2055 was signed by Governor Sam Brownback. It included critical patient safety rules that involved a communication within 5 business days from pharmacists to physicians about any biosimilar substitutions.

READ MORE

Step Therapy Legislative Update: Iowa Bill Makes Its Way to Governor’s Desk

The CSRO is pleased to announce that HF 233, step therapy bill introduced in the Iowa House by Representative Joel Fry (R, 27th) on January 23, has passed both the House and the Senate and is now headed to Governor Terry Branstad’s desk.

READ MORE

CRA: How Will Biosimilars Change Rheumatology, Rising Drug Prices: Exposing the Hidden Rebate System

The CSRO was delighted to join the California Rheumatology Alliance in an informal presentation on the effect of biosimilars on rheumatology, and an inside look at rising drug prices and the hidden rebate system controlled by pharmacy benefit managers (PBMs). The panel that presented included Dr. Greg Schmizzi on biosimilars, with Dr. Madelaine Feldman, Pharmacist Keith Bradbury, and Attorney David Balto on PBMs.

READ MORE

Biosimilars Bill Awaits Governor’s Signature in South Carolina

HB3438 has unanimously passed both legislative chambers in South Carolina, and awaits Governor Henry McMaster’s signature.

READ MORE

Biosimilars Bill Signed in New Mexico

Governor Susana Martinez signed HB260, which provides important pathways for patient access to biologic medications, while also creating much needed safety rules that include a mandate that pharmacists must communicate to physicians about a biosimilar substitution within 5 days of its dispensing.

READ MORE

Kansas’ Bill for Biosimilars Awaits the Governor’s Signature

In Kansas, HB2055 has reached approval in the House and Senate and awaits the Governor’s signature. This bill provides important pathways for access to biologic medications.

READ MORE

State Advocacy Update: Step Therapy Legislation in Texas, West Virginia, and Rhode Island

Texas Step Therapy Bill Clears Another Hurdle; West Virginia Governor Signs Step Therapy Bill into Law; Rhode Island Step Therapy Bill Scheduled for Hearing This Afternoon

READ MORE

Formulary Changes Hurt the Patients Most

Rheumatologists are at the forefront of innovative treatments for patients with complex autoimmune diseases such as rheumatoid arthritis.

READ MORE

New Legislation Could Shine a Light on the Elusive World of Prescription Drug Pricing

Ever-increasing drug prices have recently been at the forefront of the healthcare debate in America, and a new bill introduced in Congress last week may be the important first step in shedding light on the intermediaries who play a huge yet largely unnoticed role in drug pricing: Pharmacy Benefit Managers (PBMs).

READ MORE

Displaying results 1-10 (of 123)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >|